Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Steroid Sprays for Eustachian Tube Dysfunction and Serous Otitis Media
NCT00279916Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Sep 2005
- Primary completion
- Feb 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone acetonide in Eustachian tube dysfunction (ETD), otitis media with effusion (OME), sponsored by Mayo Clinic. Started Sep 2005; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
Eustachian tube dysfunction (ETD)otitis media with effusion (OME)
Beyond the preview
Go deeper on NCT00279916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00279916.